Shuang-Shuang Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuang-Shuang Dai has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Mi Zhou
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing 400038, China
4 shared publicationsTeng Yang
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing, 400038, China
4 shared publicationsWenhui He
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing 400038, China
4 shared publicationsJianbin Sun
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing, 400038, China
3 shared publicationsDan Zhong
Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences Army Medical University Chongqing China
2 shared publicationsJiabo Li
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Army Medical University, Chongqing 400038, China
2 shared publications
Latest Publications
- 24 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 778, 152387
Neutrophil extracellular traps aggravate neutrophil reverse transendothelial migration during traumatic brain injury
- 24 July 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 778, 152387
Neutrophil extracellular traps aggravate neutrophil reverse transendothelial migration during traumatic brain injury
- 13 January 2024
- Published by Elsevier in Experimental Neurology
- Vol. 374, 114691
Metabotropic glutamate receptor 5 promotes blood-brain barrier recovery after traumatic brain injury
- 13 January 2024
- Published by Elsevier in Experimental Neurology
- Vol. 374, 114691
Metabotropic glutamate receptor 5 promotes blood-brain barrier recovery after traumatic brain injury
- 6 July 2023
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 51 (5) , 557-565
Change and challenge: An online course in Medical Biochemistry and Molecular Biology
The development of information technology and portable devices has sparked a revolution in the field of education, facilitating access to diverse educational resources and lifelong learning. In particular, the COVID-19 pandemic has accelerated the transition from face-to-face to distance teaching, which requires online education to be provided worldwide. Biochemistry and Molecular Biology are key basic medical courses in laboratory-based science that cover complicated theories and applications. The balance between traditional and online courses, and the effectiveness of online courses, are fundamental to the teaching quality of Biochemistry and Molecular Biology. In this study, we explored the concepts, designs, and practices of a new blended online course and identified potential challenges. We hope that our experiences will provide new ideas for online teaching and promote teaching reform and the development of Medical Biochemistry and Molecular Biology education.
- 6 July 2023
- Published by Wiley in Biochemistry and Molecular Biology Education
- Vol. 51 (5) , 557-565
Change and challenge: An online course in Medical Biochemistry and Molecular Biology
The development of information technology and portable devices has sparked a revolution in the field of education, facilitating access to diverse educational resources and lifelong learning. In particular, the COVID-19 pandemic has accelerated the transition from face-to-face to distance teaching, which requires online education to be provided worldwide. Biochemistry and Molecular Biology are key basic medical courses in laboratory-based science that cover complicated theories and applications. The balance between traditional and online courses, and the effectiveness of online courses, are fundamental to the teaching quality of Biochemistry and Molecular Biology. In this study, we explored the concepts, designs, and practices of a new blended online course and identified potential challenges. We hope that our experiences will provide new ideas for online teaching and promote teaching reform and the development of Medical Biochemistry and Molecular Biology education.
- 11 July 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 38 (10) , 1199-1214
Histones of Neutrophil Extracellular Traps Induce CD11b Expression in Brain Pericytes Via Dectin-1 after Traumatic Brain Injury
The brain pericyte is a unique and indispensable part of the blood-brain barrier (BBB), and contributes to several pathological processes in traumatic brain injury (TBI). However, the cellular and molecular mechanisms by which pericytes are regulated in the damaged brain are largely unknown. Here, we show that the formation of neutrophil extracellular traps (NETs) induces the appearance of CD11b+ pericytes after TBI. These CD11b+ pericyte subsets are characterized by increased permeability and pro-inflammatory profiles compared to CD11b– pericytes. Moreover, histones from NETs by Dectin-1 facilitate CD11b induction in brain pericytes in PKC-c-Jun dependent manner, resulting in neuroinflammation and BBB dysfunction after TBI. These data indicate that neutrophil–NET–pericyte and histone–Dectin-1–CD11b are possible mechanisms for the activation and dysfunction of pericytes. Targeting NETs formation and Dectin-1 are promising means of treating TBI.
- 11 July 2022
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 38 (10) , 1199-1214
Histones of Neutrophil Extracellular Traps Induce CD11b Expression in Brain Pericytes Via Dectin-1 after Traumatic Brain Injury
The brain pericyte is a unique and indispensable part of the blood-brain barrier (BBB), and contributes to several pathological processes in traumatic brain injury (TBI). However, the cellular and molecular mechanisms by which pericytes are regulated in the damaged brain are largely unknown. Here, we show that the formation of neutrophil extracellular traps (NETs) induces the appearance of CD11b+ pericytes after TBI. These CD11b+ pericyte subsets are characterized by increased permeability and pro-inflammatory profiles compared to CD11b– pericytes. Moreover, histones from NETs by Dectin-1 facilitate CD11b induction in brain pericytes in PKC-c-Jun dependent manner, resulting in neuroinflammation and BBB dysfunction after TBI. These data indicate that neutrophil–NET–pericyte and histone–Dectin-1–CD11b are possible mechanisms for the activation and dysfunction of pericytes. Targeting NETs formation and Dectin-1 are promising means of treating TBI.
- Open Access
- 24 April 2022
- Published by Wiley in Cancer Science
- Vol. 113 (6) , 1955-1967
Glutamate blunts cell‐killing effects of neutrophils in tumor microenvironment
Neutrophils are the first defenders of the innate system for injury and infection. They have gradually been recognized as important participants in tumor initiation and development due to their heterogeneity and plasticity. In the tumor microenvironment (TME), neutrophils can exert antitumor and protumor functions, depending on the surroundings. Tumor cells systemically alter intracellular amino acid (AA) metabolism and extracellular AA distribution to meet their proliferation need, leading to metabolic reprogramming and TME reshaping. However, the underlying mechanisms that determine how altered AAs affect neutrophils in TME are less‐explored. Here, we identified that abundant glutamate releasing from tumor cells blunted neutrophils’ cell‐killing effects toward tumor cells in vitro and in vivo. Mass spectrometric detection, flow cytometry, and western blot experiments proved that increased levels of pSTAT3/RAB10/ARF4, mediated by glutamate, were accompanied with immunosuppressive phenotypes of neutrophils in TME. We also discovered that riluzole, an FDA‐approved glutamate release inhibitor, significantly inhibited tumor growth by restoring neutrophils’ cell‐killing effects and decreasing glutamate secretion from tumor cells. These findings highlight the importance of tumor‐released glutamate on neutrophil transformation in TME, providing new possible cancer treatments targeting altered glutamate metabolism.
- 24 April 2022
- Published by Wiley in Cancer Science
- Vol. 113 (6) , 1955-1967
Open AccessGlutamate blunts cell‐killing effects of neutrophils in tumor microenvironment
Neutrophils are the first defenders of the innate system for injury and infection. They have gradually been recognized as important participants in tumor initiation and development due to their heterogeneity and plasticity. In the tumor microenvironment (TME), neutrophils can exert antitumor and protumor functions, depending on the surroundings. Tumor cells systemically alter intracellular amino acid (AA) metabolism and extracellular AA distribution to meet their proliferation need, leading to metabolic reprogramming and TME reshaping. However, the underlying mechanisms that determine how altered AAs affect neutrophils in TME are less‐explored. Here, we identified that abundant glutamate releasing from tumor cells blunted neutrophils’ cell‐killing effects toward tumor cells in vitro and in vivo. Mass spectrometric detection, flow cytometry, and western blot experiments proved that increased levels of pSTAT3/RAB10/ARF4, mediated by glutamate, were accompanied with immunosuppressive phenotypes of neutrophils in TME. We also discovered that riluzole, an FDA‐approved glutamate release inhibitor, significantly inhibited tumor growth by restoring neutrophils’ cell‐killing effects and decreasing glutamate secretion from tumor cells. These findings highlight the importance of tumor‐released glutamate on neutrophil transformation in TME, providing new possible cancer treatments targeting altered glutamate metabolism.
- 1 July 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 79, 114-124
Transplantation with mGluR5 deficiency bone marrow displays antidepressant-like effect in C57BL/6J mice
- 1 July 2019
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 79, 114-124
Transplantation with mGluR5 deficiency bone marrow displays antidepressant-like effect in C57BL/6J mice